Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
4.400
+0.080 (1.85%)
Jan 21, 2025, 4:00 PM EST - Market closed
Biodexa Pharmaceuticals Employees
Biodexa Pharmaceuticals had 21 employees as of December 31, 2023. The number of employees decreased by 6 or -22.22% compared to the previous year.
Employees
21
Change (1Y)
-6
Growth (1Y)
-22.22%
Revenue / Employee
$4,995
Profits / Employee
-$410,371
Market Cap
2.56M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
BDRX News
- 2 months ago - Result of General Meeting - GlobeNewsWire
- 2 months ago - Gaining Momentum, Biodexa is Advancing Two Recent Acquisitions Through the Clinic - Accesswire
- 2 months ago - Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Regains Compliance For Continued Listing on Nasdaq - GlobeNewsWire
- 2 months ago - Notice of General Meeting - GlobeNewsWire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Biodexa Pharmaceuticals Plc (BDRX) And Encourages Shareholders to Reach Out - Accesswire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biodexa Pharmaceuticals Plc (BDRX) and Encourages Investors to Learn More About the Investigation - Accesswire
- 3 months ago - Biodexa Pharmaceuticals Plc (BDRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 3 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Biodexa Pharmaceuticals Plc (BDRX) And Encourages Stockholders to Reach Out - Accesswire